The American Hospital Association input on the FDA report on the risks and benefits to health and safety that are associated with non-device software as required under Section 3060 of the 21st Century Cures Act.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
The American Hospital Association provides comments on the Consumer Product Safety Commission’s agenda and priorities for fiscal years 2027 and 2028.
the American Hospital Association provides comments on the Rural Health Transformation Program.
American Hospital Association (AHA) comments on the Centers for Medicare & Medicaid Services (CMS) interim final rule on Medicaid community engagement requirements.
This letter provides comment on the American Hospital Association's support of the National Nursing Workforce Center Act of 2025 (S. 1482).
The American Hospital Association comments on the CMS proposed rule regarding Medicaid managed care state-directed payments and Medicaid fee-for-service targeted practitioner payments.
AHA responds to Information Collection Request about the Health Resources and Services Administration’s proposed 340B Rebate Model Program.
AHA comments on the CMS’ request for information on the Essential Health Benefits (EBH) framework and the Affordable Care Act’s requirement that the scope of EHB be equal to the scope of benefits provided under a typical employer plan.
The American Hospital Association's comment on the Office of Management and Budget’s (OMB’s) and other agencies’ proposed revisions to the Uniform Grants Regulation governing federal financial assistance.
The American Hospital Association (AHA) appreciates the opportunity to comment on the Office of the Trade Representative’s proposed duties on certain economies under section 301 of the Trade Act of 1974.